259 related articles for article (PubMed ID: 25614967)
21. Covalently dimerized Camelidae antihuman TNFa single-domain antibodies expressed in yeast Pichia pastoris show superior neutralizing activity.
Ji X; Lu W; Zhou H; Han D; Yang L; Wu H; Li J; Liu H; Zhang J; Cao P; Zhang S
Appl Microbiol Biotechnol; 2013 Oct; 97(19):8547-58. PubMed ID: 23324801
[TBL] [Abstract][Full Text] [Related]
22. Production and characterization of a genetically engineered anti-caffeine camelid antibody and its use in immunoaffinity chromatography.
Franco EJ; Sonneson GJ; DeLegge TJ; Hofstetter H; Horn JR; Hofstetter O
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(2):177-86. PubMed ID: 19560409
[TBL] [Abstract][Full Text] [Related]
23. mRNA display selection and solid-phase synthesis of Fc-binding cyclic peptide affinity ligands.
Menegatti S; Hussain M; Naik AD; Carbonell RG; Rao BM
Biotechnol Bioeng; 2013 Mar; 110(3):857-70. PubMed ID: 23108907
[TBL] [Abstract][Full Text] [Related]
24. Expression of soluble and functional human neonatal Fc receptor in Pichia pastoris.
Lee CH; Choi DK; Choi HJ; Song MY; Kim YS
Protein Expr Purif; 2010 May; 71(1):42-8. PubMed ID: 20006709
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin specificity of TG19318: a novel synthetic ligand for antibody affinity purification.
Fassina G; Verdoliva A; Palombo G; Ruvo M; Cassani G
J Mol Recognit; 1998; 11(1-6):128-33. PubMed ID: 10076825
[TBL] [Abstract][Full Text] [Related]
26. Cyclic peptide ligand with high binding capacity for affinity purification of immunoglobulin G.
Kang HJ; Choe W; Min JK; Lee YM; Kim BM; Chung SJ
J Chromatogr A; 2016 Sep; 1466():105-12. PubMed ID: 27608618
[TBL] [Abstract][Full Text] [Related]
27. Selection and Characterization of Specific Nanobody Against Human Immunoglobulin G.
Kazemi-Lomedasht F; Behdani M; Rahimpour A; Habibi-Anbouhi M; Poshang-Bagheri K; Shahbazzadeh D
Monoclon Antib Immunodiagn Immunother; 2015 Jun; 34(3):201-5. PubMed ID: 26090598
[TBL] [Abstract][Full Text] [Related]
28. Purification of human immunoglobulin G via Fc-specific small peptide ligand affinity chromatography.
Yang H; Gurgel PV; Carbonell RG
J Chromatogr A; 2009 Feb; 1216(6):910-8. PubMed ID: 19117576
[TBL] [Abstract][Full Text] [Related]
29. Tandem nanobody: A feasible way to improve the capacity of affinity chromatography.
Huang Y; Fu J; Zhong Y; Shuai W; Zhang H; Li Y; He Q; Tu Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1173():122678. PubMed ID: 33839466
[TBL] [Abstract][Full Text] [Related]
30. Prolonged in vivo residence times of llama single-domain antibody fragments in pigs by binding to porcine immunoglobulins.
Harmsen MM; Van Solt CB; Fijten HP; Van Setten MC
Vaccine; 2005 Sep; 23(41):4926-34. PubMed ID: 15992972
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of Clostridium difficile toxin-specific single-domain antibodies.
Hussack G; Arbabi-Ghahroudi M; Mackenzie CR; Tanha J
Methods Mol Biol; 2012; 911():211-39. PubMed ID: 22886255
[TBL] [Abstract][Full Text] [Related]
32. Purification of soluble recombinant human FcgammaRII (CD32).
Gruel N; Chapiro J; Fridman WH; Teillaud JL
Prep Biochem Biotechnol; 2001 Nov; 31(4):341-54. PubMed ID: 11765899
[TBL] [Abstract][Full Text] [Related]
33. Protein binder for affinity purification of human immunoglobulin antibodies.
Heu W; Choi JM; Lee JJ; Jeong S; Kim HS
Anal Chem; 2014 Jun; 86(12):6019-25. PubMed ID: 24877609
[TBL] [Abstract][Full Text] [Related]
34. A specific nanobody-based affinity chromatography resin as a platform for small ubiquitin-related modifier fusion protein purification.
Huang Z; Hua H; Du X; Zhen Z; Zhao W; Feng J; Li JA
J Chromatogr A; 2024 Jan; 1713():464508. PubMed ID: 38006661
[TBL] [Abstract][Full Text] [Related]
35. Novel peptide ligand with high binding capacity for antibody purification.
Lund LN; Gustavsson PE; Michael R; Lindgren J; Nørskov-Lauritsen L; Lund M; Houen G; Staby A; St Hilaire PM
J Chromatogr A; 2012 Feb; 1225():158-67. PubMed ID: 22251884
[TBL] [Abstract][Full Text] [Related]
36. Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics.
Schoch A; Kettenberger H; Mundigl O; Winter G; Engert J; Heinrich J; Emrich T
Proc Natl Acad Sci U S A; 2015 May; 112(19):5997-6002. PubMed ID: 25918417
[TBL] [Abstract][Full Text] [Related]
37. Alpaca (Lama pacos) as a convenient source of recombinant camelid heavy chain antibodies (VHHs).
Maass DR; Sepulveda J; Pernthaner A; Shoemaker CB
J Immunol Methods; 2007 Jul; 324(1-2):13-25. PubMed ID: 17568607
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of a camelid single-domain antibody directed to human CD22 biomarker.
Faraji F; Tajik N; Behdani M; Shokrgozar MA; Zarnani AH; Shahhosseini F; Habibi-Anbouhi M
Biotechnol Appl Biochem; 2018 Sep; 65(5):718-725. PubMed ID: 29543347
[TBL] [Abstract][Full Text] [Related]
39. Qualification of a homogeneous cell-based neonatal Fc receptor (FcRn) binding assay and its application to studies on Fc functionality of IgG-based therapeutics.
Mathur A; Arora T; Liu L; Crouse-Zeineddini J; Mukku V
J Immunol Methods; 2013 Apr; 390(1-2):81-91. PubMed ID: 23384837
[TBL] [Abstract][Full Text] [Related]
40. Antibody variable region interactions with Protein A: implications for the development of generic purification processes.
Ghose S; Allen M; Hubbard B; Brooks C; Cramer SM
Biotechnol Bioeng; 2005 Dec; 92(6):665-73. PubMed ID: 16206278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
